11-117395596-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014956.5(CEP164):​c.2963C>G​(p.Thr988Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 1,613,384 control chromosomes in the GnomAD database, including 71,395 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6249 hom., cov: 32)
Exomes 𝑓: 0.30 ( 65146 hom. )

Consequence

CEP164
NM_014956.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0690

Publications

29 publications found
Variant links:
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CEP164 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • nephronophthisis 15
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, G2P
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029549599).
BP6
Variant 11-117395596-C-G is Benign according to our data. Variant chr11-117395596-C-G is described in ClinVar as Benign. ClinVar VariationId is 260482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.307 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP164NM_014956.5 linkc.2963C>G p.Thr988Ser missense_variant Exon 24 of 33 ENST00000278935.8 NP_055771.4 Q9UPV0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP164ENST00000278935.8 linkc.2963C>G p.Thr988Ser missense_variant Exon 24 of 33 1 NM_014956.5 ENSP00000278935.3 Q9UPV0-1
CEP164ENST00000533223.1 linkn.3845C>G non_coding_transcript_exon_variant Exon 10 of 16 1
CEP164ENST00000533675.5 linkn.3190C>G non_coding_transcript_exon_variant Exon 18 of 27 2
CEP164ENST00000533706.5 linkn.2287C>G non_coding_transcript_exon_variant Exon 17 of 27 5

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
43049
AN:
151950
Hom.:
6245
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.268
Gnomad AMI
AF:
0.338
Gnomad AMR
AF:
0.210
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.268
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.339
Gnomad NFE
AF:
0.310
Gnomad OTH
AF:
0.293
GnomAD2 exomes
AF:
0.273
AC:
68514
AN:
250808
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.269
Gnomad AMR exome
AF:
0.147
Gnomad ASJ exome
AF:
0.246
Gnomad EAS exome
AF:
0.273
Gnomad FIN exome
AF:
0.297
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.274
GnomAD4 exome
AF:
0.297
AC:
433911
AN:
1461316
Hom.:
65146
Cov.:
45
AF XY:
0.296
AC XY:
215237
AN XY:
726916
show subpopulations
African (AFR)
AF:
0.267
AC:
8946
AN:
33462
American (AMR)
AF:
0.159
AC:
7085
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.251
AC:
6547
AN:
26126
East Asian (EAS)
AF:
0.298
AC:
11820
AN:
39694
South Asian (SAS)
AF:
0.267
AC:
22993
AN:
86154
European-Finnish (FIN)
AF:
0.296
AC:
15787
AN:
53382
Middle Eastern (MID)
AF:
0.287
AC:
1622
AN:
5658
European-Non Finnish (NFE)
AF:
0.307
AC:
341658
AN:
1111796
Other (OTH)
AF:
0.289
AC:
17453
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
17103
34206
51308
68411
85514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11120
22240
33360
44480
55600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
43062
AN:
152068
Hom.:
6249
Cov.:
32
AF XY:
0.281
AC XY:
20881
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.268
AC:
11108
AN:
41438
American (AMR)
AF:
0.210
AC:
3210
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
933
AN:
3472
East Asian (EAS)
AF:
0.276
AC:
1421
AN:
5152
South Asian (SAS)
AF:
0.268
AC:
1293
AN:
4826
European-Finnish (FIN)
AF:
0.280
AC:
2970
AN:
10592
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.310
AC:
21097
AN:
67982
Other (OTH)
AF:
0.295
AC:
623
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1601
3203
4804
6406
8007
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.299
Hom.:
2293
Bravo
AF:
0.275
TwinsUK
AF:
0.299
AC:
1109
ALSPAC
AF:
0.314
AC:
1211
ESP6500AA
AF:
0.267
AC:
1176
ESP6500EA
AF:
0.309
AC:
2658
ExAC
AF:
0.279
AC:
33887
Asia WGS
AF:
0.266
AC:
926
AN:
3478
EpiCase
AF:
0.312
EpiControl
AF:
0.307

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephronophthisis 15 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 12, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
9.9
DANN
Benign
0.92
DEOGEN2
Benign
0.0094
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.060
N
LIST_S2
Benign
0.54
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
2.0
M
PhyloP100
-0.069
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.80
N
REVEL
Benign
0.013
Sift
Benign
0.16
T
Sift4G
Benign
0.47
T
Polyphen
0.0030
B
Vest4
0.029
MutPred
0.070
Gain of phosphorylation at T988 (P = 0.058);
MPC
0.10
ClinPred
0.0027
T
GERP RS
0.95
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.037
gMVP
0.034
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305830; hg19: chr11-117266312; COSMIC: COSV54042361; COSMIC: COSV54042361; API